ALK and lung carcinoma: Peer-reviewed articles from the last ten years were selected using the combination of the following keywords: “lung cancer genetics”, “targeted therapy lung cancer”, “EGFR mutations”, “ALK rearrangements”, and “immune checkpoint inhibitors”, without any restriction.